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Abstract
Background: Ticks cause massive damage to livestock and vaccines are one sustainable substitute for the acaricides
currently heavily used to control infestations. To guide antigen discovery for a vaccine that targets the gamut of parasitic
strategies mediated by tick saliva and enables immunological memory, we exploited a transcriptome constructed from
salivary glands from all stages of Rhipicephalus microplus ticks feeding on genetically tick-resistant and susceptible bovines.
Results: Different levels of host anti-tick immunity affected gene expression in tick salivary glands; we thus selected four
proteins encoded by genes weakly expressed in ticks attempting to feed on resistant hosts or otherwise abundantly
expressed in ticks fed on susceptible hosts; these sialoproteins mediate four functions of parasitism deployed by male
ticks and that do not induce antibodies in naturally infected, susceptible bovines. We then evaluated in tick-susceptible
heifers an alum-adjuvanted vaccine formulated with recombinant proteins. Parasite performance (i.e. weight and
numbers of females finishing their parasitic cycle) and titres of antigen-specific antibodies were significantly reduced or
increased, respectively, in vaccinated versus control heifers, conferring an efficacy of 73.2%; two of the antigens were
strong immunogens, rich in predicted T-cell epitopes and challenge infestations boosted antibody responses against
them.
Conclusion: Mining sialotranscriptomes guided by the immunity of tick-resistant hosts selected important targets and
infestations boosted immune memory against salivary antigens.
Keywords: Rhipicephalus microplus tick, Sialotranscriptome, Anti-tick vaccine, Antigen discovery, Salivary proteins
Background
Infestations with ticks cause enormous losses in live-
stock. Rhipicephalus microplus, the most important spe-
cies of tick affecting cattle worldwide, is predominantly
found in tropical and subtropical regions [1]; it is a
monoxene tick, i.e. it spends its approximately 21-days
parasitic cycle (larvae, nymphs and adults) on the same
host. Thereafter, most of the engorged females detach
from the host to begin laying thousands of eggs in the
pasture. Current control strategies primarily involve the
use of acaricides leading to acaricide-resistant ticks, en-
vironmental pollution and meat and milk contaminated
with residues [2]. These concerns reduce the usefulness
of this approach, and thus alternative strategies for the
control of tick infestations are being evaluated. Tick
bites stimulate host immune responses [3], indicating
that the induction of protective immunity against ticks
might be achieved using vaccines and immunobiological
control of these pests is feasible. The commercially avail-
able anti-tick recombinant vaccines, TickGard [4] and
GAVAC [5], are based on a tick gut glycoprotein, Bm86,
and the concept of hidden antigens. Hidden antigens, to
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which hosts are not exposed to during natural infesta-
tions, were considered to be superior to salivary-exposed
antigens based on the rationale that parasites would not
have developed escape mechanisms from host immune
responses against them [6, 7], in spite of the fact that
tick saliva mediates most mechanisms of parasitism [8].
However, while these vaccines do reduce parasitism,
their efficacy proved too variable and the memory in-
duced by them short-lived [9–12], i.e. less than ideal for
production systems for livestock. Therefore, the search
for new tick antigens and new strategies for antigen se-
lection is essential to improve the control of tick infest-
ation through vaccination.
The discovery of protective antigens for the develop-
ment of a new cattle tick vaccine depends on rational
strategies, and many efforts have been undertaken [13].
The post-genomic era facilitated the rational design of
safer and effective vaccines based on the genome, prote-
ome or transcriptome of parasites [14]. Here, we focus
on the analysis of a differential sialotranscriptome from
ticks fed on susceptible or resistant hosts, as a strategy
for antigen discovery, because tick saliva is the main me-
diator of parasitic haematophagy [8]. In addition, expos-
ure of vaccinated animals to saliva during natural
challenges will boost immunological memory [15], thus
avoiding the problems seen with vaccines formulated
with non-salivary antigens. Our hypothesis for develop-
ing a tick vaccine is that it must be formulated with a
cocktail of tick salivary antigens to weaken the gamut of
parasitic strategies. We also hypothesise that host im-
munity modulates gene expression in ticks, including
important vaccine targets. We generated a R. microplus
tick transcriptome to be our catalogue for antigen dis-
covery in order to explore important information and,
consequently, vaccine targets that are not covered by the
available cattle tick databases (BmiGI [16] and Cattle-
TickBase [17]), i.e. the sequencing data obtained with
ticks feeding on tick-resistant and tick-susceptible hosts.
Although CattleTickBase is a very comprehensive data-
base for R. microplus, sequencing data related to ticks
fed on Holstein and Nelore bovines (the most common
taurine and zebuine breeds in Brazil, respectively), has
not been generated yet, therefore, the sequence data pro-
duced here will significantly enlarge the repertoire of
ESTs for this species of tick.
Our catalogue was generated with cDNA libraries con-
structed with salivary glands of ticks undergoing different
conditions, such as life stages and feeding on hosts with
contrasting levels of anti-tick immunity. Regarding host
immunity, bovine host breeds present differences in im-
munity to ticks, reflecting variable genetic backgrounds;
for example, zebu cattle (Bos taurus indicus) are resistant
to tick infestations, whereas taurine cattle (B. t. taurus)
are susceptible to tick infestations [18–20]. The novelty of
our strategy is that we considered the anti-tick immunity
phenotypes of hosts to drive antigen discovery. We also
assumed that transcripts encoding salivary proteins im-
portant for parasitism are efficiently expressed when ticks
feed on susceptible hosts, thereby providing a successful
life-cycle for the ectoparasite and representing adequate
antigens for targeting. Therefore, we aimed to identify the
antigens affected by host immunity for the development
of a multicomponent anti-tick vaccine for testing in tick-
susceptible bovines and to evaluate whether vaccination
can control tick infestation. To the best of our knowledge,
taking into consideration the impact of host anti-tick im-
munity on gene expression in a tick has never been used
for the identification of new antigens for the development
of an anti-tick vaccine for cattle.
Among the list of antigens, three candidate genes were
expressed as N-terminal truncated recombinant tagged
proteins and a fourth candidate was expressed as a full-
length sequence. The putative biological functions of these
proteins were related to suppression of host antibody re-
sponses via an immunoglobulin binding-protein; inhib-
ition of host hemostatic responses via a thrombin
inhibitor; possibly destruction of host extracellular matrix
for the formation of a feeding pool via a metalloprotease;
attachment of the tick to its hosts via a glycine-rich ce-
ment protein. The immunisation of Holstein calves (a
breed highly susceptible to tick infestations) with the four
test antigens significantly reduced the infestation of R.
microplus ticks in vaccinated calves, with an efficacy of
73.2%. Two of these antigens induced a recall antibody re-
sponse of antigen-specific IgG in calves exposed to tick
bites (infestation). The results presented herein are a proof
of principle that a reverse vaccinology pipeline guided by
different levels of anti-tick immunity is a powerful strategy
for the identification of promising antigens that can boost
host immunity during the natural infestation, and that sal-
ivary (“exposed antigens”) proteins are useful components
of cattle tick vaccine.
Methods
Ticks
For the construction of cDNA libraries (tick transcrip-
tomes), feeding nymphs and male and female adults
were collected from naturally infested Bos taurus taurus
cattle (Holstein breed; the susceptible host) and B. t.
indicus (Nelore breed; the resistant host). Salivary glands
(SG) were dissected from 25 females, 25 males and 40
nymphs that fed on each type of host, and the samples
were briefly washed in ice-cold PBS and immediately
stored in RNALater solution (Ambion, Austin, TX,
USA) for 24 h at 4 °C, followed by freezing at -70 °C
until further use. Unfed larvae (UFL) of R. microplus
ticks were obtained 3 days after hatching from eggs laid
by females that had fed on resistant or susceptible
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bovines. The UFL were frozen at -70 °C and stored until
further use.
For challenges with R. microplus infestations in the
vaccination trial, the larvae were obtained from eggs laid
by engorged female ticks collected from bovines natur-
ally infested. These females were maintained at 28 °C
and 90% relative humidity until oviposition. The egg
masses were weighed at the third day of oviposition and
aliquots of 500 mg (equivalent to approximately 10,000
hatched larvae) were used for artificial tick infestations
with unfed larvae inserted in cotton jersey chambers, 2
weeks after the third dose of the immunisation regimen.
The cattle undergoing challenge infestations were
followed daily during the whole parasitic cycle (21 days).
Rhipicephalus microplus sialotranscriptomes
A total of eight cDNA libraries were constructed:
UFLRmS (unfed larvae hatched by females fed on sus-
ceptible hosts), UFLRmR (unfed larvae hatched by fe-
males fed on resistant hosts), SGNRmS (salivary glands
of nymphs fed on susceptible hosts), SGNRmR (salivary
glands of nymphs fed on resistant hosts), SGMRmS (sal-
ivary glands of males fed on susceptible hosts),
SGMRmR (salivary glands of males fed on resistant
hosts), SGFRmS (salivary glands of females fed on sus-
ceptible hosts) and SGFRmR (salivary glands of females
fed on resistant hosts). Because of collection and dissec-
tion of fed larvae is not feasible, at this stage, we ana-
lysed gene expression of a whole extract of unfed larvae
hatched from eggs laid by females fed on susceptible or
resistant hosts (respectively, UFLRmS and UFLRmR).
ESTs from each library (excluding rRNA, mitochondrial
and low-complexity sequences) were deposited in the
European Nucleotide Archive (Accession numbers
LT708478–LT714108). Isolation of RNA, construction of
cDNA libraries, amplification of clones (PCR using re-
combinant phages as templates) and sequencing were
performed as described elsewhere [21, 22]. For all librar-
ies, cDNA size fractionation was performed using
Chroma-Spin 400 (Clontech Laboratories, Mountain
View, CA, USA) before ligation in λTriplEx2 arms. The
cDNA fractions were pooled in three main sizes named
small (S), medium (M) and large (M) to ligate these
three sizes of cDNA to the vector in different reactions,
to obtain representative libraries for all fragment sizes.
Bioinformatics tools used for R. microplus
sialotranscriptome analyses
A detailed description of the bioinformatics treatment of
the data has been provided elsewhere [21, 23]. Briefly,
the ESTs (raw sequences) were trimmed of primer and
vector sequences, clustered into contigs (with built-in
BLAST [24] and CAP3 assembler [25] algorithms. The
contigs were further analysed against several databases,
such as the Non-Redundant (NR) protein NCBI data-
base, Gene Ontology (GO) database [26], and the Con-
served Domain Database (CDD) [27] containing the
KOG [28], Pfam [29], SMART [30] motifs as well as
custom-downloaded databases containing the mitochon-
drial and rRNA nucleotide sequences available at NCBI.
A database containing 42,512 ESTs from R. microplus
available at EST/NCBI database (LIBEST_014697 BEA
library; BmiGI database [31]) also was used. We submit-
ted all translated contig sequences to the Signal P server
[32] to detect signal peptides indicative of secreted pro-
teins. The counting of ESTs in a contig belonging to
each library was used in a chi-square (χ2) test to analyse
differences in the distribution of ESTs in the contigs,
using the chisq.test function in Excel, in which all results
with P < 0.05 we considered statistically significant. A
chi-square test was performed apart for contigs Rm39,
Rm180 and Rm239 using SigmaPlot 11.0 (Systat Soft-
ware, Inc, Sao Jose, CA, USA) to obtained the expected
counts of ESTs outputted by the report software. The
final output of bioinformatics analyses was piped into a
tab-delimited file imported into a hyperlinked Excel spread-
sheet (RMallHxN dataset, Table S1, Additional file 1; since
the bioinformatics pipeline is built on a Windows system,
we advise that Additional file 1: Table S1 is opened from a
PC-Windows-based operating system.
Anti-tick multicomponent vaccine: selection of target
genes for molecular cloning and recombinant protein
production
Candidate genes for anti-tick vaccines were selected
from the comparative transcriptome analysis of ticks fed
on susceptible or resistant bovines described herein. The
selection criteria included (i) the presence of signal pep-
tide (for saliva secretion) and/or significant blast result
with a tick salivary protein previously described; (ii) up-
regulation in the transcriptome of ticks fed on suscep-
tible bovine compared to resistant hosts; and (iii)
important putative function in parasitism, according to
BLAST hits in the NR-NCBI database. In addition, for
selected candidate genes, epitope predictions were per-
formed using BepiPred method [33] through IEDB-AR
(Immune Epitope Database Analysis Resource) [34] for
B-cell epitope, as described previously for screening of
cattle tick vaccine antigens [35] and TEPITOPE software
[36] and NetMHCII 2.2 server [37, 38] for T-cell epi-
topes, both sequence-based methods restricted to HLA-
II binding peptides. Target gene sequences were ampli-
fied using phage lambda clones from cDNA libraries as
templates and specific primers for each gene. The re-
combinant proteins were produced and named as Rm39,
Rm180 and Rm239 (as reference to their contig number
in RMallHxH dataset) and all were found to be truncated
(partial, incomplete sequence), because the last two, the
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template phage were not full-length ORF (open reading
frame) cDNA clones (5' end sequence corresponding to
N-terminus of the protein were missing), and the first
one presented the glycine repeats at the C-terminus por-
tion. Both cloning and recombinant protein expression
were performed according to the instructions of the
Champion™ pET Directional TOPO Expression kit (Life
Technologies, Carlsbad, California, USA). Briefly, the
PCR products were cloned into the expression vector
pET100, and the recombinant His-tagged proteins were
produced as insoluble inclusion bodies in Escherichia
coli BL21Star. The bacteria were harvested and lysed in
lysis buffer (8 M urea and 20 mM Tris, pH 8.0). The re-
combinant proteins were purified in the presence of
8 M (condition for insoluble proteins) urea using
HisTrap HP Ni-Sepharose affinity columns (GE
Healthcare, Piscataway, New Jersey, USA) according
to the manufacturer’s instructions, connected on an
AKTA-FPLC system (GE Healthcare, Piscataway, New
Jersey, USA). The purified denatured recombinant
proteins were refolded as described previously [39]
with some modifications. Briefly, the dialysis was per-
formed at 4 °C against 2 l of refolding buffer (25 mM
Tris, pH 7.5, 250 mM NaCl, 0.5 mM DTT, 0.1% so-
dium deoxycholate, 2.5% glycerol and 2–6 M urea) to
gradually decrease the urea concentration (three
changes, four hours each). Subsequently, the recom-
binant proteins were dialysed against 0.9% NaCl and
checked in 15% polyacrylamide gel electrophoresis
(SDS-PAGE). The protein quantification was per-
formed through band densitometry of PAGE using
ImageJ [40] to estimate the recombinant protein
amount compared to a reference protein (BSA, bovine
serum albumina) loaded in known quantities (2 μg,
10 μg and 20 μg). Endotoxin contamination was de-
termined using QCL-1000 Endpoint Chromogenic
LAL Assays (Lonza, Walkersville, Maryland, USA). A
fourth recombinant protein, named as Rm76 (IgG binding
protein C), which was predicted to be putatively glycosyl-
ated was expressed (full-length ORF) in F293 mammalian
cells (performed by Life Technologies), and also used for
the experimental vaccination of cattle. The sequences of
antigens were deposited in the ENA/EMBL-EBI database
(accession numbers LT795749–LT795752). An SDS-PAGE
using 15% polyacrylamide gels and Coomassie blue staining
of the E. coli-expressed proteins is shown in Fig. S1,
Additional file 2. Adding 4 kDa from the expression vector
(histidine tag), the molecular weights of the predicted pro-
teins were confirmed.
Vaccination of cattle and challenge with R. microplus
Purebred Holstein calves (3–7-month-old females) were
purchased from a tick-free farm and individually housed
in stalls with containment fencing at the Institute of
Animal Sciences (Nova Odessa, SP, Brazil). The stalls
were monitored daily to prevent tick infestation during
vaccination to guarantee contact with ticks upon chal-
lenge with an artificial infestation. As the calves were of
different ages and some of the animals were half-
siblings, these animals were arranged based on age and
kinship to obtain a varied age group, with minimal gen-
etic background effects.
Purified recombinant proteins in saline (0.9% NaCl)
were prepared using an aluminium hydroxide adjuvant
at a 1:8 (protein:adjuvant) ratio under sterile conditions.
Rm39, Rm180 and Rm239 were prepared, separately, in
a mixture containing 100 μg of recombinant protein in a
2 ml dose; Rm76 was prepared as a 25 μg/2 ml dose.
Each calf in the vaccinated group (n = 4) was
intramuscularly injected in the neck with the four
recombinant proteins (in separate injections) using a
3-ml syringe and a 21G needle, three times with 3-
weeks intervals (days 0, 21 and 42 of the trial). The
calves from the control group (n = 4) were injected
with saline and adjuvant alone.
At 2 weeks after the last immunisation, the vaccinated
and control groups were challenged with 10,000 R. micro-
plus larvae in cotton jersey chambers attached on top of
the shoulders of the animals (one cell in each body side,
infested with 5,000 larvae each). The parasitological pa-
rameters of challenge tick infestations were evaluated by
counting and weighing the engorged females that spon-
taneously dropped off at 20, 21 and 22 days of infestation
and assessing egg oviposition and egg fertility as previ-
ously described [41]. These parameters were used for
calculation of vaccine efficacy (E) applying a formula with
vaccinated/control group data detailed elsewhere [41, 42].
Briefly, the overall protection (E) conferred through effi-
cient vaccination was calculated based on the effect of the
number of ticks (NT, adult female ticks), tick weight (aver-
age adult female weight), oviposition (O, average weight of
the egg masses per surviving tick), and egg fertility (F,
average weight of the larvae per gram of eggs), applying
the formula 100 × [1-(CRT ×CRO×CRF)], where CRT,
CRO and CRF represent the reduction of NT, O and F,
respectively, of vaccinated group (V) compared with the
adjuvant/saline control group (C), respectively, i.e. CRT =
NTV/NTC, CRO =OV/OC and CRF = FV/FC. The tick
infestation in one animal from the control group was not
considered because the attached cotton cells were dam-
aged, compromising the artificial infestation. The calves
were maintained according to the guidelines of the
Committee for Ethics in Animal Experimentation of the
Ribeirão Preto School of Medicine, University of São
Paulo (CETEA-FMRP/USP, certificate numbers 055/2007,
210/2008 and 102/2009). Student’s t-test (P < 0.05) was
used to compare the results between vaccinated and
control groups.
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Detection of antigen-specific antibodies in calf serum
Blood samples were collected from each calf to obtain
the sera at different time points: before, after experimen-
tal vaccination and during the challenge (larvae infest-
ation). Serum antigen-specific total IgG, IgG1 and IgG2
antibodies were determined through a standard protocol
of an indirect ELISA using 0.15 μg/well of purified re-
combinant Rm39, Rm180, Rm239 and Rm76 sera at
1:50, 1:100 and 1:300 dilutions and incubation with
1:1,000 sheep anti-bovine IgG1 or IgG2-HRP conjugated
antibodies (Bethyl Laboratories, Montgomery, Texas,
USA), or sera at 1:100, 1:500 and 1:1000 dilutions (for
total IgG antigen-specific measurements) and incubation
with 1:5,000 rabbit anti-bovine IgG-HRP conjugated sec-
ondary antibody (Sigma-Aldrich, St Louis, Missouri,
USA). The colour reaction was developed using the
TMB Microwell Peroxidase Substrate System (Kierke-
gaard Perry Labs, Gaithersburg, Maryland). The levels of
antigen-specific total IgG and IgG1/IgG2 in the immu-
nised and control calves were expressed as the OD450
value for the 1:500 and 1:100 serum dilutions respect-
ively, and compared between vaccinated and control cat-
tle using ANOVA (P < 0.05) and Bonferroni’s post-hoc
test. The OD450 values for the control group were
expressed as the average measurements of all antigens
(Rm39, rm239, Rm180 and Rm76). For Western blot
analysis, the recombinant proteins (10 μg) were trans-
ferred from 12% polyacrylamide SDS-PAGE gels to
Hybond ECL nitrocellulose sheets (GE Healthcare,
Piscataway, NJ) using a TE 70 semi-dry transfer unit (GE
Healthcare). Membranes were incubated with pooled
sera (1:100) from non-infested and infested bovines
(Holsteins, tick-susceptible breed), collected as previ-
ously described [43], or pooled sera (1:100) from
vaccinated bovines and sheep anti-bovine IgG1 or IgG2
as secondary antibodies (1:1000). The chemilumines-
cence detection method was performed using ECL
Western Blotting Substrate (Thermo Scientific Pierce,
Rockford, Illinois, USA) for horseradish peroxidase
(HRP) on an ImageQuant 350 Detection System (GE
Healthcare).
Results
Characterisation of R. microplus cDNA libraries for antigen
discovery
It is well known that blood feeding and reproductive ef-
ficiency is impaired when ticks feed on resistant host
[44]. To ascertain how anti-tick host immunity affects
gene expression of R. microplus ticks, we analysed eight
cDNA libraries of ticks fed on susceptible or resistant
hosts (Holsteins and Nelores, respectively). The analysed
cDNA libraries were: salivary glands of nymphs, males and
females fed on genetically susceptible or resistant hosts
(SGNRmS, SGNRmR, SGMRmS, SGMRmR, SGFRmS and
SGFRmR).
More than 10,500 clones were randomly sequenced
from the eight non-amplified cDNA libraries A total of
7,923 high-quality expressed sequence tags (ESTs) from
the eight libraries were obtained, that were assembled
into 3,342 unique contigs referred to as the RMallHxN
dataset, and functionally annotated (Additional file 1).
The distribution of contigs, number of ESTs and single-
tons were similar for all libraries.
The ESTs in individual libraries and the combined
dataset (RMallHxN) were first grouped into major func-
tional categories: housekeeping, secreted, unknown,
unknown secreted, transposable elements (TE) and
viral-like (Fig. 1). The proportion of these different
Fig. 1 Classification of ESTs from R. microplus cDNA libraries. The eight cDNA libraries are represented individually according to the tick’s life stage
and which host the tick parasitized. The eight libraries (OVERALL) comprise the RmallHxN dataset. TE: transposable elements. a For larvae samples,
whole tick crude extract were used to construct cDNA libraries, because salivary glands isolation are not possible for this life stage. b The
proportions were calculated considering all libraries together rather than separate displayed for eight bars above OVERALL
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categories varying across the libraries primarily
depended on the life stage rather than the source of
feeding (host), except for nymphs, which presented dis-
tinct proportions of housekeeping and secreted tran-
scripts. Interestingly, libraries from male ticks presented
the highest proportion of putative secreted proteins with
known functions (Fig. 1, ranging from 43.9 to 47.0%),
stressing the differences between males, females and
nymphs, and suggesting the potential diversity and/or
amount of proteins in male saliva. The putative secreted
proteins with unknown functions were altered in a simi-
lar ratio for females, males and nymphs, comprising
more than half of the proportion of the transcripts for
larvae libraries. Beyond the quantitative variation, we ob-
served some differences in the transcriptional profile
through the manual annotation of the contigs (Add-
itional file 1). Indeed, depending on the source of blood
meal, i.e. ticks fed on susceptible or resistant hosts, the
expression of many transcripts was altered.
Functional classification of secreted proteins from the
RMallHxN dataset (Table 1), revealed that the majority
(12.9%) of these proteins belonged to the glycine-rich
protein family, which was also previously found to abun-
dantly represented in R. microplus [22] and R. sangui-
neus [45] cDNA libraries. This family has a variety of
primary functions in ticks involving attachment onto
host skin, i.e. fixation, which is essential to ticks start the
blood feeding. Expression of glycine-rich proteins has
been associated with tick biology (monoxene or hetero-
xene ticks, and hypostome morphology and size of the
cement cone) [22]. Salivary proteins important for
haematophagous parasitism, such as proteases (metallo-
proteases, serine proteases, calpain and serine carboxy-
peptidases) and proteinase inhibitors (with up to 1%
belonging to the Kunitz family), comprised 2.45% of the
putative secreted proteins (Table 1).
To determine the novelty rate of the RMallHxN
dataset in comparison with the R. microplus ESTs
database, we blasted the 3,342 contigs in the
RMallHxN dataset against the BmiGI database, a
database of R. microplus ESTs published by Guerrero
and colleagues, obtained from a cDNA library (called
LIBEST_014697 BEA available at EST/NCBI database)
of different tissues and life stages of R. microplus
[46]. It contains 45,512 ESTs resulting in a total of
13,643 unique transcripts [46]. Notably, 47.2% of the
contigs in the RMallHxN dataset has no BLAST hits
against the BmiGI database (Additional file 1, column
AW, “Best match to BEA database”). Many factors
may have influenced in this high level of novelty ob-
served in our transcriptome, such as the strategy
employed for the construction of the cDNA libraries,
starting with the mRNA from target tissue (salivary
glands) of ticks feeding on resistant hosts and, most
importantly, the contig assembling parameters employed
by our bioinformatics pipeline.
Selection and production of tick salivary gland antigens
The analysis of the comparative transcriptome from R.
microplus ticks fed on susceptible or resistant hosts
(RMallHxN dataset) generated a catalogue of transcripts
that were differentially expressed according to the origin
of the blood meal, and this catalogue was used to select
potential candidates for the development of a cattle tick
vaccine. We applied the following criteria to select genes
for evaluation as potential vaccine antigens: (i) the pres-
ence of a signal peptide, indicating secretion in saliva or
significant blast result with tick secreted salivary protein
Table 1 Functional classification of putative secreted proteins in
the RMallHxN dataset comprising eight libraries (UFLRmS,
UFLRmR, SGNRmS, SGNRmR, SGMRmS, SGMRmR, SGFRmS
and SGFRmR)
Functional class Total contigs Total ESTs % of total
Related to host immunitya 12 23 0.29
TIL domain 16 34 0.43
Proteinase inhibitors
Kunitz domain 30 87 1.10
Serpin 1 2 0.03
Thyropin domains 1 2 0.03
Cystatin 1 1 0.01
Carboxypeptidase inhibitor 2 3 0.04
Lipocalins/histamine binding
proteins
35 61 0.77
Immunoglobulin binding
proteins
4 57 0.72
Mucins 13 31 0.39
Basic tail family 10 22 0.28
Enzymes
Metalloproteases 20 48 0.61
Calpain 6 7 0.09
Serine protease 10 42 0.53
Serine carboxypeptidases 2 2 0.03
Antigen 5 family 4 23 0.29
Glycine rich family
Cement proteins 112 1024 12.92
GYY family 15 70 0.88
GGY family 4 8 0.10
Other secreted proteins 12 13 0.16
R. microplus-specific proteins 107 296 3.74
Unknown secreted 2,082 2,836 35.79
aThese transcripts encoding proteins that may play role in modulation of host
immunity. They were classified as “similar to protein associated with
interferon”, “microplosin family”, “DAP-36 immunosuppressant family”,
“Evasin”, “Defensin” and “Ixoderin” as displayed on Additional file 1
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described previously; (ii) important putative function for
haematophagous parasitism; and (iii) upregulation of ex-
pression in ticks feeding on a susceptible host. Because
biochemical functional characterization studies for R.
microplus salivary gland proteins are scarce, the second
criterion was based on the blast result with proteins that
probably play a role in haematophagy, i.e. sequence simi-
larities with proteins predicted by other sialotranscrip-
tome studies to be involved in coagulation,
immunosuppression, anti-inflammatory responses and
tick attachment.
Based on these criteria, we listed a few dozen of
antigen candidates from the RMallHxN dataset
(Additional file 1) to be tested as vaccine targets. Here,
we described the first trial of an immunisation test, in
which 11 priority candidates (all with putative function
in haemostasis, host immunomodulation and tick at-
tachment) were chosen to start the procedures of PCR
amplification, cloning and protein production. We suc-
cessfully cloned and expressed three N-terminal-
truncated recombinant salivary proteins, Rm39, Rm180
and Rm239, in an Escherichia coli system. The tran-
scripts encoding Rm39, Rm180, and Rm239 showed
similarity to glycine-rich proteins, serine protease inhibi-
tors and metalloproteases, respectively and all of these
transcripts were significantly increased in ticks fed on
susceptible hosts (Table 2). The cloned sequences en-
code N-terminal histidine-tagged proteins of 54, 67 and
145 amino acids corresponding to theoretical molecular
weights of 5.8, 7.9 and 16.5 kDa, respectively (Table 2).
The phage clones for Rm180 and Rm239 amenable to
cloning procedures were not full-length sequences, in
which portions of 5' end sequence for both were miss-
ing, therefore the recombinant proteins were produced
as N-terminal truncated. The full-length sequences for
Rm180 and Rm239 were obtained further with a high-
resolution sialotranscriptome obtained by next-generation
sequencing (unpublished data, NCBI BioProject
PRJNA329522). Although the contig Rm39 presented a
full-length sequence (Additional file 1), we cloned only the
54 amino acids at the C-terminal portion, where repeats
containing glycines are located.
As Rm76 and Rm239 vaccine candidates are larger
than Rm180 and Rm39, they probably contain more
antigenic determinants. Then, we analysed these selected
antigens regarding their immunogenicity using in silico
epitope prediction methods for both T-cell and B-cell
epitopes. T cell epitope prediction was restricted to
MHC class II because we believe that the antibody re-
sponse helped by antigen-specific CD4+ T cells will be
the protective immunological mechanism elicited by an
efficacious tick vaccine, in which the specific antibodies
produced against saliva components neutralise the ac-
tion of these tick proteins on hosts during the hemato-
phagy. Since there is no available tool to predict BoLA
class II binding peptides, we used resources available for
human alleles, such as TEPITOPE and NetMHCII.
As shown in Table 3, Rm239 and Rm76 antigens were
richer in peptides that bind MHC class II alleles as well
as richer in peptides that bind to a broader range of
MHC class II alleles. When we considered the native
antigen (complete protein sequence), Rm239 presented
the most numerous T-cell epitopes, which can be partly
explained by its long protein sequence. Despite the simi-
lar lengths of Rm180 and Rm76 native antigens, the lat-
ter presented eight times more epitopes. Rm39
presented the lowest numbers of binding peptides. Simi-
lar epitope prediction profiles were observed with both
tools (Table 3), i.e. Rm76 and Rm239 presented more
MHC class II binding peptides.
To predict B-cell epitopes, we used BepiPred that
combines a hidden Markov model and a propensity scale
method (Parker Hydrophilicity [47]) to identify potential
sites in protein (linear peptides highly prone to be ex-
posed on native protein surface) that are recognised by
antibodies. As observed for T-cell epitope prediction,
Table 2 Characteristics of candidate antigens from the R. microplus transcriptome selected using reverse vaccinology for assessment
in an anti-tick vaccine
Transcripts from cDNA libraries (RMallHxN dataset) Recombinant protein Full-length sequencee
Developmental
stage
No. ESTs
in RmRa
Expected No.
ESTs in RmRj
No. ESTs
in RmSb
Expected No.
ESTs in RmS j
P valuec Amino
acids
MWd
(kDa)
Amino
acids
MW
(kDa)
Rm39 All stages 21 30 44 34 0.033f Rm39 54 5.8 Rm39 105 11
Rm180 Female, Nymph, Male 5 14 27 18 < 0.001g Rm180 67 7.9 Rm180 186 20.8
Rm239 Nymph, Male 7 18 26 14 0.007h Rm239 145 16.5 Rm239 500 55
aR. microplus ticks fed on resistant hosts
bR. microplus ticks fed on susceptible hosts
cChi-square test using SigmaPlot 11.0 software
dMolecular weight calculated without a histidine tag. The size of tagged recombinant proteins is shown in Additional file 2: Figure S1
eComplete sequences of antigens
fChi-square test, χ2 = 4.531, df = 1
gChi-square test, χ2 = 10.864, df = 1
hChi-square test, χ2 = 7.343, df = 1
jExpected counts were obtained from software report
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Rm76 and Rm239 were predicted to present more anti-
genic determinants (Fig. 2a, b, respectively) than Rm180
and Rm39 (Fig. 2c, d, respectively). Together, these epi-
tope predictions suggested that Rm76 and Rm239 might
elicit a better antibody repertoire.
We were unable to confirm whether these tick salivary
antigens are consistently produced in saliva during a
blood meal or whether they are secreted on a specific
day of feeding (e.g. using Western blot of tick saliva with
anti-Rm39 or anti-Rm239 or anti-Rm180 antibodies).
However, we gathered indirect confirmation that at least
Rm239 and Rm76 (or very closely related proteins) are
secreted in saliva because we observed an elevation in
antibody titres for these antigens after the challenge
infestation, i.e. tick bites (with inoculation of saliva;
described in the next section).
Vaccination of calves with the tick recombinant salivary
proteins
The candidate antigens to be evaluated in this study are
predicted to function at the tick-host interface because
they presented as upregulated transcripts when R. micro-
plus ticks feed on susceptible hosts. Thus, we propose
that bovines infested with ticks could develop an anti-
body response to neutralise the effects of these salivary
antigens during infestation provided they are properly
delivered to the host.
To evaluate the capacity of the selected antigens to in-
duce protection against tick infestations, we immunised
Holstein calves with the recombinant R. microplus saliv-
ary proteins Rm39, Rm76, Rm180 and Rm239. The vac-
cinated group received three separate doses of the four
recombinant antigens at 3-week intervals, followed by
Table 3 Epitope prediction of HLA-II-restrict T cells using Rm39,
Rm180, Rm239 and Rm76 protein sequences with TEPITOPE and
NetMHCII software
TEPITOPE
Native antigen
(full-length sequence)
No. of
peptidesa
No. of
allelesb
Scorec
Rm239 (500 amino acids) 2,023 54 31.22
Rm76 (152 amino acids) 867 54 30.85
Rm180 (186 amino acids) 105 53 43.27
Rm39 (105 amino acids) 38 34 4.05
Recombinant vaccine antigend
(partial sequence)
Positionf No. of allelesb Scoreg
Rm180 25 53 24.9
Rm39 69 5 0.6
30 9 2.3
Rm239 79 2 0.23
59 27 3.06
38 5 1.30
Rm76e 157 52 24.5
137 52 9.7
132 52 2.4
129 53 6.2
122 53 25.7
121 53 17.8
120 52 7.5
117 54 5.7
116 53 5.0
66 52 15.0
62 35 3.3
56 53 22.1
50 1 1.2
46 53 11.9
40 53 5.0
39 53 15.7
37 3 2.4
36 53 12.0
NetMHCII
Recombinant vaccine
antigene
No of
peptidesh
No of
Allelesi
Strong
ligandsj
Rm180 52 10 33
Table 3 Epitope prediction of HLA-II-restrict T cells using Rm39,
Rm180, Rm239 and Rm76 protein sequences with TEPITOPE and
NetMHCII software (Continued)
Rm39 72 6 –
Rm239 130 14 75
Rm76 e1 138 14 166
aTotal number of epitopes with positive score
bA total of 54 HLA-DR alleles were used by TEPITOPE. The values refer to the
number of HLA-DRB alleles that binds to predicted epitopes
cThe score (ranging from negative to positive values) is a calculated value to
define the binding affinity between peptide and HLA, therefore the higher the
score, the higher the binding affinity. The values are expressed as the mean of
scores from predicted bindings
dData from sequences (partial) of recombinant proteins used in this study
eRm76 was the only antigen cloned as full-length sequence
fPosition of the first amino acid of the HLA class II binding peptide on the
protein sequence
gOnly the positive scores were considered, i.e. those with the most binding
affinity properties
hTotal number of possible peptides based on each protein size
iA total of 14 HLA-DR alleles were used by NetMHCII v. 2.2. The values refer to
the number of alleles that presents predicted ligands
jThe binding affinity to HLA-DR is based on IC50 values in nM. The threshold
for strong ligands is IC50 = 50. Only results for strong ligands are shown
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challenge with R. microplus larvae at 2 weeks after the
last immunisation.
We observed that the feeding time on ticks fed on vacci-
nated animals was slowed and the ticks did not present the
typical aspect of fully engorged females by the 22nd day of
challenge infestation. This was reflected by the significant
reduction in the number of female ticks (52.5%; t-test,
t(3.292), df = 3, P < 0.0460) and tick engorgement weight
(55.2%; t-test, t(2.830), df = 5, P < 0.0367) that were observed
in vaccinated calves (Table 4) when compared to calves
that received adjuvant alone. The weight of egg masses
and their hatching rates tended to be smaller in vacci-
nated animals relative to the same parameters observed
in ticks fed on control animals. However, the differences
were not found to be statistically significant. Vaccination
with recombinant salivary antigens induced an overall
protection of 73.2% in the vaccinated calves, according to
the formula for calculations of vaccine efficacy (Table 4).
Because tick numbers and tick weights were significantly
reduced, we conclude that some or all of the salivary
antigens tested were able to control tick infestations in
vaccinated animals.
Fig. 2 B-cell epitope predictions. The sequences for recombinant salivary proteins Rm76 (a), Rm239 (b), Rm180 (c) and Rm39 (d) were used to
predict linear B-cell epitopes with BepiPred method through IEDB-AR web-based repository. The red line represents the threshold value to assign
epitope sites across amino acids position in protein sequences. Only predicted peptides longer than six amino acids were depicted
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The antigen-specific antibody response was evaluated in
both experimental groups according to the measurements
of total IgG, IgG1 and IgG2 antigen-specific antibodies in
the sera of the calves before and after the vaccination (1
week after the third injection) and also upon challenge
with R. microplus ticks (Fig. 3). The measurements for
Rm76 showed that a significant induction of anti-Rm76
antibodies was elicited after vaccination, with a major con-
tribution of the IgG2 subclass (Fig. 3d). Despite not being
significant, the levels of total IgG anti-Rm239 also pre-
sented a small increase after the vaccination. Interestingly,
a significant increase in the levels for total IgG anti-
Rm239 antibodies was reached during challenge infest-
ation (Day 72, adult infestation period, Fig. 3b, c), most
likely due to a major contribution of IgG1 subtype re-
sponse took place (Fig. 3c). In general, we observed that
the Rm239 and Rm76 antigens induced a significant anti-
body response in vaccinated animals for IgG1 and IgG2
subtypes (ANOVA, F(1.521, 44) = 6.234, P < 0.001; F(3.299, 44)
= 22.09, P < 0.001; Fig. 3c, d, respectively).
The antigen-specific IgG1 response induced by Rm239
antigen after vaccination (Fig. 3c, Day 49) was drastically
reduced 1 week later (Fig. 3c, Day 55). The half-life of
IgG1 is shorter than IgG2 [48], a fact that might explain
this finding. Noteworthy, however, is the early recall pro-
duction of anti-Rm239 IgG1 antibodies 2 days after chal-
lenge with R. microplus larvae exhibited by the
vaccinated calves (Fig. 3c, Day 57), a response that per-
sisted until the adult life stage of the tick (Fig. 3c, Day
72) and began decreasing at the end of infestation
(Fig. 3c, Day 79). Future studies should observe antibody
titers after the second infestation of cattle.
The host response against Rm76 exhibited significant
levels of specific IgG2 when compared with the adjuvant
control group, reaching peak levels 1 week after vaccination
(Fig. 3d, Day 49). Moreover, at day two after challenge with
R. microplus (Fig. 3d, Day 57), levels of anti-Rm76 IgG2
were considerably reduced and then subsequently increased
during infestation at the adult tick stage (Fig. 3d, Day 72).
The reduction in the antibody response observed 2 days
after challenge (Fig. 3d, Day 57) might be due to the immu-
nomodulatory effects of tick infestation, through the several
immunosuppressant molecules in tick saliva [44, 49], in
addition to the modulatory immune responses mounted by
susceptible hosts themselves, such as the acute phase pro-
tein haptoglobin, which rises during infestations [50].
Haptoglobin presents a negative effect on the immune
system [51], including the inhibition of the antibody
response to T-cell dependent antigens and immunoglobulin
synthesis [52].
The results obtained for the Rm239 and Rm76 anti-
gens suggested that these salivary proteins are produced
and secreted into the saliva of ticks during blood feed-
ing, as both proteins stimulated a specific recall antibody
response during the post-challenge period (specific IgG1
anti-Rm239 and anti-Rm76 and specific anti-Rm76
IgG2). Levels of both anti-Rm76 IgG1 and IgG2 anti-
bodies were low during the larval stage of infestation
and increased at the adult stage. With the depth of se-
quencing reached in this study the sialotranscriptome
analyses showed that Rm239 was expressed in nymphs
and male ticks (Table 2). Future studies using techniques
such as quantitative PCR and Western blotting should
be done to determine if Rm239 is also expressed and
produced in larvae and adult salivary gland tissues.
Antigen-specific antibody production and the results of
the sialotranscriptome analyses are consistent with the
production of Rm76 in male ticks (Additional file 1). In
summary, Rm239 and Rm76 were demonstrated to be
most suitable antigens to naturally boost the immune re-
sponse in vaccinated animals. Antibody titres against
Rm76 and Rm239 antigens (total IgG, IgG1 and IgG2)
are available in Additional file 3: Figure S2.
Unexpectedly, specific IgG subtype (IgG1/IgG2) re-
sponses against Rm39 and Rm180 were not detected by
ELISA (Fig. 3). Despite not being statistically significant,
an increase of total IgG anti-Rm39 was observed at the
end of infestation, while the total IgG anti-Rm180
Table 4 Control of R. microplus infestation in cattle vaccinated with recombinant salivary antigens selected from the comparative
transcriptome of ticks fed on susceptible or resistant hosts
Parameters of parasitism
Experimental
groupa
Percent reduction in
tick burden (no. of
adult females)b
Percent reduction in tick
weight (adult female
weight in mg)b
Percent reduction in oviposition
(egg masses weight in mg per
survived tick)b
Percent reduction in egg fertility
(larvae weight in grams of per
gram of eggs)b
Efficacy
(%)c
Vaccinated 52.5 (587 ± 189)** 55.2 (151 ± 51)** 18% (88 ± 20) 27.2 (0.016 ± 0.006) 72
Adjuvant/saline control 1,233 ± 51 338 ± 29 107.5 ± 8.7 0.022 ± 0.014 –
After 2 weeks of last immunization dose calves were challenged with 10,000 larvae. Because R. microplus is a monoxenic tick, infestations are evaluated by
counting of engorged females and their reproductive efficiency
aHolstein calves with kinship were separated in different groups (vaccinated group, n = 4; control group, n = 3)
bPercent reduction was determined in relation to the control group. Mean ± SE values are in parentheses. Student’s t-test was used to compare vaccinated and
control groups (**P < 0.05)
cVaccine efficacy based on the reduction in the number of female ticks (CRT), oviposition (CRO) and egg fertility (CRF) compared with the control group using the
formula 100 [1-(CRT × CRO × CRF)]
Maruyama et al. Parasites & Vectors  (2017) 10:206 Page 10 of 16
remained detectable at low levels. Thus, we performed
SDS-PAGE followed by immunoblotting for Rm39,
Rm180 and Rm239 using the pooled sera from vacci-
nated and control calves to evaluate the antibody re-
sponse to a second method. Analysis of the antibody
recognition patterns of Rm39, Rm180 and Rm239 pro-
teins in vaccinated animals through Western blot re-
vealed that the animals from the vaccinated group
produced IgG1 antibodies against the three recombinant
salivary proteins at 7 and 14 days after the third immun-
isation, but that the tick infestation did not stimulate the
IgG1 recall response for the Rm39 and Rm180 antigens
(Fig. 4a). The same recognition pattern was observed for
IgG2 antibodies but at a much lower intensity. The
pooled sera obtained from the vaccinated group did not
recognise the recombinant salivary antigens before vac-
cination, as expected (Fig. 4a, “bv” lanes), and similar re-
sults were obtained for the pooled sera obtained from
the control group (data not shown).
We also performed immunoblotting for Rm76 using
pooled sera obtained from the vaccinated and control
groups. The animals produced IgG1 antibodies after
vaccination and during tick infestation (Fig. 4b). IgG2
antibody production was delayed 1 week compared
with IgG1, and IgG2 antibodies were also detected
Fig. 3 Antigen-specific IgG (total), IgG1 and IgG2 antibody
responses upon vaccination and challenge with R. microplus.
a Schematic representation of vaccination trial indicating the
measurement periods of antigen-specific antibody responses.
b Indirect ELISA was used to evaluate total IgG and its subclasses,
IgG1 (c) and IgG2 (d) antigen-specific antibody responses in sera
from vaccinated and adjuvant control bovines. The data represented
the average of duplicate values at 1:500 dilution for total IgG and
1:100 dilutions for IgG subtypes
Fig. 4 Antigen-specific antibody recognition for denatured Rm39,
Rm180, Rm239 and Rm76 antigens. Western blot analysis of the
recombinant salivary proteins Rm39, Rm180, Rm239 (a) and Rm76
(b) using pooled sera (1:100) from vaccinated calves for the
evaluation of antibody responses to linear epitopes. Abbreviations:
Bv, before vaccination; 1wpv, 1 week post-third shot of vaccination;
2wpv, 2 weeks post-third shot of vaccination; cainf, challenge
infestation (bovines infested with ticks in adult stage); clinf, challenge
infestation (bovines infested with ticks in larvae stage); einf, end
of infestation
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against Rm76 at 14 days after vaccination and during
tick infestation (Fig. 4b). The immunoblotting results
of Rm239 and Rm76 corroborated the observations in
ELISA measurements. Through Western blot we
detected a specific antibody response (the majority
being of the IgG1 subtype) for Rm39 and Rm180.
However, these antibodies were not strongly elicited
during challenge tick infestations, as observed for
Rm239 and Rm76 antigens. Furthermore, the antibody
responses were in line with the findings for epitope
predictions.
Discussion
William Trager demonstrated more than seven decades
ago that immune responses are induced against ticks
through the bites they inflict during repeated infestations
[53] that these responses could be passively transferred
to naïve hosts by serum. These host responses resulted
in damage to feeding ticks and reduced acquisition of
blood by female ticks during subsequent infestations on
both actively and passively immune hosts [53] and vali-
dated the notion that stimulation of immunity against
tick proteins using vaccines is an adequate and sustain-
able alternative to control infestations. Trager also
showed that salivary glands were the most efficient tis-
sue with which to induce anti-tick immunity. However,
the remarkable results above were described for unnat-
ural tick-host associations (Dermacentor variabilis and
Guinea pigs), but Trager described in the same paper
that anti-tick immunity does not develop as promptly in
natural tick-host associations (D. variabilis and Peromys-
cus leucopus), perhaps because the specialized tick saliva
can selectively block their hosts’ immunity and inflam-
mation [54]. Much later, Brown et al. [55] and Shapiro
et al. [56] showed that immunisations of hosts with frac-
tions of tick saliva induced similar detrimental effects
upon a tick’s life-cycle. In spite of this early success, and
perhaps due to the difficulties posed by natural tick-host
associations, antigen selection for development of bovine
anti-tick vaccines was subsequently diverted from testing
salivary antigens towards a preference for “hidden” or
“concealed” tick antigens, thus called because the host is
not exposed to them during natural infestations and,
consequently, the tick would not have developed an es-
cape mechanism for these potential vaccine targets. All
of the commercially available anti-tick vaccines were de-
veloped based on this principle, but they present variable
efficacies and still require the application of acaricides
for tick control [57]. Thus, development of an effective
anti-tick vaccine is still in demand. The premise of the
approach adopted in the present work is that the vaccine
antigens should be involved in important biological pro-
cesses for parasitism, i.e. salivary antigens. Furthermore,
memory can be boosted since vaccinated hosts will be
exposed to tick saliva during challenges. Lastly, the vac-
cine must comprise a multi-component formulation to
decrease variations in vaccine performance due to
genetic diversity in bovines and tick strains and also to
cover the main functions of saliva in all stages of parasit-
ism. Importantly, this strategy can affect various stages
of the tick’s life-cycle resulting in decreases in tick
populations to levels better tolerated by cattle.
Our results show that mining the sialotranscriptome and
larvae transcriptome based on differential expression mod-
ulated by host anti-tick immunity is helpful for the identifi-
cation of protective vaccine antigens. Rodriguez-Valle et al.
[58] were the first to evaluate if host anti-tick immunity af-
fects transcript expression patterns when ticks fed on Bos
indicus (tick-resistant) or Bos taurus (tick-susceptible) cat-
tle. For this, they employed a microarray based on the
BmiGI database [31], which contains transcripts of ticks fed
on Bos taurus hosts. With this approach, they demon-
strated that the genetic composition of bovine hosts
changes the gene expression profile in ticks during blood
meals. Besides corroborating these findings by Rodriguez-
Valle et al. the present study generated a transcriptome
using a sequencing-based approach, which provides not
only the expression pattern (up- or downregulation), but
also enables the identification of transcripts exclusively
expressed in one condition.
In this first trial, described herein, we selected some
candidates and were able to produce successfully four
recombinant antigens and tested them as multicompo-
nent tick vaccine. Vaccinated animals were able to con-
trol infestations using the reduction of tick burden and
tick engorgement. Future studies in a larger number of
animals, immunised with a larger diversity of antigens,
assessment of dose regimens and also formulation with
other adjuvants should be undertaken to improve the
outcomes observed using this strategy.
An approach of similar thinking has been applied to
antigen discovery for vaccine-based prevention of the
schistosomiases by screening protein libraries with sera
from schistosomiasis-resistant and chronically infected
humans [59]. Herein, we selected gene candidates for
immunisation of bovines genetically susceptible to in-
festation with a multi-component vaccine. After chal-
lenge with R. microplus larvae, the tick infestation was
significantly controlled in the vaccinated bovines, show-
ing 73.2% vaccine efficacy. Additionally, we have evalu-
ated the gene expression profiles elicited by this
recombinant vaccine to ascertain molecular signatures;
this analysis will provide more details about the response
of the host to vaccination and infestation.
Large-scale searches for protective antigens against
ixodidae ticks has been performed such as for Ixodes
[60, 61], and R. microplus species [62, 63]. However, the
screening strategies either target tissues that do not
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mediate parasitism directly (e.g. cultured IDE8 embry-
onic I. scapularis cells) and/or performed large-scale
screening of expression libraries with sera from infested
hosts, which will not necessarily recognise all the useful
targets in saliva. Indeed, the salivary antigens tested in
the present work were silent antigens and did not readily
elicit immune responses in Holstein bovines successively
infested with ticks (data not shown). In addition, none of
these antigens target candidates whose expression and
production was affected through the natural immunity
of the host. The differential expression of salivary tran-
scripts in response to host immunity associated with the
putative function of the proteins provided insight into
the important antigens involved at the tick/host inter-
face. Other differential transcriptome data [14] of ticks
fed on resistant or susceptible bovines were obtained
using a customised microarray based on the BmiGI data-
base, i.e. it is represented only by transcripts from ticks
fed on a susceptible host and, furthermore, without
tissue-specific resolution. Our data shows that several
transcripts are expressed only in ticks feeding on resist-
ant hosts (see Additional file 1).
Many of the antigens evaluated as anti-tick vaccines in
cattle, i.e. embryo proteins [64], ferritin 2 [42], subolesin
and ubiquitin [62], 5'-nucleotidase [65], Bm95 [66, 67],
and the Bm86 antigen from commercial vaccines [4], are
concealed antigens. Although vaccination with these an-
tigens elicits an antibody response [68], these proteins
are not exposed to the hosts through tick bites, and the
memory immune responses against them are not stimu-
lated through saliva as a natural boost in immunity
against ectoparasites. Alternatively, to the extent that
some of these intracellular proteins are secreted to the
host perhaps by a holocrine mode, these vaccines may
be effective, but proof of secretion in this non-canonical
form is missing for the majority of targets, except for the
tick histamine release factor [69]. Therefore, vaccines
that use only concealed antigens require several booster
injections for the maintenance of immunity in vacci-
nated animals, which is expensive and difficult to man-
age in livestock.
Recent trials with similar goals deserve special com-
ment: they used the candidate gene approach and tested
single proteins from R. microplus in cattle. The function
of one of these antigens [70], a metalloprotease, is simi-
lar to one antigen tested in this study, however, it
afforded lower protection, and one of four animals did
not respond, supporting the need for a cocktail vaccine.
Another antigen, an aquaporin derived from tick gut
[71], afforded a level of efficacy similar to this study’s
vaccine, but challenge infestations did not boost the level
of antibodies foreboding poor memory, similar to what
occurs with commercial vaccines, which employ gut an-
tigens. A third trial employed a salivary antigen, acidic
ribosomal protein P0, conjugated to keyhole limpet
haemocyanin (KLH) that afforded an efficacy of 96%
[72]. However, that study did not ascertain if the carrier
induced cross-reactivity to tick haemocyanins and the
antibody responses to the antigen were variable and
boosts by the challenge cannot be established as well.
In our initial vaccination trial using a multi-
component vaccine containing four recombinant salivary
antigens, we observed that specific antibody production
was efficiently stimulated against two antigens, Rm239
and Rm76, after immunisation and during infestation
with R. microplus. The Rm239 and Rm76 salivary anti-
gens possess putative metalloprotease and IgG binding
functions, respectively. The neutralisation of these saliv-
ary proteins during tick infestation through specific IgG
subtypes antibodies might represent one of the mecha-
nisms involved in protection against ticks. Impairing im-
portant salivary proteins can be effective for the control
of tick infestations. Notably, the dynamics of reactivity
of IgG1 with those antigens was complex, whereas IgG2
displayed more uniform patterns of reactivity with
Rm239 and Rm76. Those results suggest that salivary
antigen-specific IgG exhibit varied half-lives, whereby
several factors could influence their degradation and
clearance as: the subclass [48], amino acid composition
of Fab regions determined by specificity [73] and pat-
terns of glycosylation [74, 75]. Importantly, these two re-
combinant salivary antigens, Rm239 and Rm76,
indicated that tick saliva elicits a recall antibody re-
sponse, even during the early stages of infestation, and
possibly elicits the protection observed in the vaccinated
group, consistent with the results obtained herein.
Conversely, the recombinant salivary antigens Rm39
and Rm180 maybe induced a small repertoire of specific
antibodies, primarily comprising IgG1, which recognised
epitopes after immunisation, but not during the first in-
festation. They presented lower immunogenicity than
Rm76 and Rm239, a finding that was subsequently con-
firmed by B-cell and T-cell epitope prediction analyses.
Further studies testing successive challenge infestations
should be done to ascertain if repetitive infestation will
boost the immune responses to weakly immunogenic
Rm39 and Rm180 antigens. Also, modifications in vaccine
formulations for the Rm39 and Rm180 antigens should be
performed to increase the antibody response stimulated
through immunisation. These salivary proteins should be
further studied and considered as potential antigens be-
cause these proteins might be involved in mechanisms
that underlie the tick blood feeding process. Since Rm180
salivary antigens possess putative serine protease inhibitor
functions, these proteins could disturb certain host hom-
oeostasis processes involving serine proteases. The Rm39
salivary antigen shares similarities with extracellular
matrix proteins and this protein could act as a decoy for
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the host. Accordingly, these antigens might play important
roles in subversion mechanisms to evade host immune re-
sponses directed against tick salivary proteins, as parasites
present a wide range of mechanisms to escape from host
defences, including haematophagous parasites, such as
ticks [76]. Interestingly, the scores obtained in the
TEPITOPE and NetMHVII v2.2 T cell epitope prediction
algorithms for Rm39 and Rm180 antigens indicated that
they present fewer T cell epitopes than the Rm239 and
Rm76 antigens. These algorithms employ HLA alleles;
however other authors have shown that they can also pre-
dict the immunogenicity of antigens for bovines [77, 78].
In summary, the results reported herein show that our
approach is promising as a strategy to identify new cattle
tick vaccine antigens. The effective control of tick infesta-
tions through immunological interventions as vaccines
still depends on the discovery and evaluation of other anti-
gens. In addition, the formulation of a multi-component
anti-tick vaccine comprising both types of antigens,
exposed and concealed, might be more helpful by decreas-
ing the effects of cattle genetic diversity, providing a nat-
ural boost through the saliva and escaping the selective
pressure of the host.
Conclusions
This work is significant for antigen discovery because
our strategy applies to other parasites. It is also signifi-
cant for scientists working on tick vaccines, for pro-
ducers affected by tick infestations and for consumers
concerned about contamination of environment and
food products with acaricides. Here we show that tick
sialotranscriptome analyses guided by the immunity of
tick-resistant hosts selected important vaccine targets
and that tick vaccine targeting a range of immunogenic
tick salivary proteins weaken parasitism, boost immune
memory and can achieve sustainable tick control.
Additional files
Additional file 1: Annotated sialotranscriptome (RMallHxN dataset) of
the Rhipicephalus microplus tick. (.docx) available at http://
exon.niaid.nih.gov/transcriptome/Rhip_microplus/2015-07/Table_S1.zip.
(DOCX 25 kb)
Additional file 2: Figure S1. Recombinant salivary proteins of
Rhipicephalus microplus. Partial sequences of the selected candidates
Rm39, Rm180 and Rm239 were expressed in E. coli. SDS-PAGE using 15%
polyacrylamide gels and Coomassie blue staining (.tiff). Adding 4 kDa
from the expression vector (histidine tag), the molecular weights of the
predicted proteins were confirmed. (TIF 115 kb)
Additional file 3: Figure S2. Antigen-specific antibody titres for Rm239
and Rm76 antigens. (DOCX 310 kb)
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